Biomarker-based corticosteroid adjustment in severe asthma: a modified Delphi consensus

ERJ Open Res. 2018 Dec 7;4(4):00081-2018. doi: 10.1183/23120541.00081-2018. eCollection 2018 Oct.

Nicola E Gallagher¹, Catherine E Hanratty¹, Marc Humbert^{2

3}, Elisabeth Bel⁴, Ratko Djukanovic^{5

6}, Valerie Hudson⁷, Nile Amos⁷, Liam G Heaney^{1

6}

¹ Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK.
² Univ. Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
³ Service de Pneumologie, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
⁴ Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands.
⁵ NIHR Southampton Biomedical Research Centre, Southampton, UK.
⁶ RASP-UK, London, UK.
⁷ Asthma UK RASP-UK Patient Input Platform, London, UK.

Abstract

UK asthma physicians are supportive of biomarker-based steroid adjustment, but European physicians need more evidence http://ow.ly/sTrf30my3jw.